With the goal of improving the lives of people affected by cancer, oncology research at Bayer is working on developing new cancer treatments and making them available to patients who need them. A key aspect of Bayer’s research is identifying suitable molecular targets at different stages of tumour evolution with the aim of killing tumour cells and stopping tumour growth.

To find out more click here:   http://pharma.bayer.com/en/innovation-partnering/research-focus/oncology/survival-signaling/